Cargando…
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells
BACKGROUND: Mantle cell lymphoma (MCL) is a rare, highly heterogeneous type of B-cell non-Hodgkin’s lymphoma. The sumoylation pathway is known to be upregulated in many cancers including lymphoid malignancies. However, little is known about its oncogenic role in MCL. METHODS: Levels of sumoylation e...
Autores principales: | Hanel, Walter, Lata, Pushpa, Youssef, Youssef, Tran, Ha, Tsyba, Liudmyla, Sehgal, Lalit, Blaser, Bradley W., Huszar, Dennis, Helmig-Mason, JoBeth, Zhang, Liwen, Schrock, Morgan S., Summers, Matthew K., Chan, Wing Keung, Prouty, Alexander, Mundy-Bosse, Bethany L., Chen-Kiang, Selina, Danilov, Alexey V., Maddocks, Kami, Baiocchi, Robert A., Alinari, Lapo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277803/ https://www.ncbi.nlm.nih.gov/pubmed/35831896 http://dx.doi.org/10.1186/s40164-022-00293-y |
Ejemplares similares
-
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
por: Brown-Burke, Fiona, et al.
Publicado: (2023) -
Novel targeted therapies for mantle cell lymphoma
por: Alinari, Lapo, et al.
Publicado: (2012) -
Transducin b-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma
por: Youssef, Youssef, et al.
Publicado: (2020) -
Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy
por: Annunzio, Kaitlin, et al.
Publicado: (2022) -
Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma
por: Choueiry, Fouad, et al.
Publicado: (2021)